171 related articles for article (PubMed ID: 34889033)
1. A new valid rhabdomyosarcoma spheroid culture model for in vitro evaluation of hypericin-based photodynamic therapy.
Hempfling L; Adamus A; Wagner BR; Engel N; Seitz G
Pediatr Blood Cancer; 2022 Aug; 69(8):e29482. PubMed ID: 34889033
[TBL] [Abstract][Full Text] [Related]
2. Hypericin and its radio iodinated derivatives - A novel combined approach for the treatment of pediatric alveolar rhabdomyosarcoma cells in vitro.
Ocker L; Adamus A; Hempfling L; Wagner B; Vahdad R; Verburg FA; Luster M; Schurrat T; Bier D; Frank M; Lisec J; Engel N; Seitz G
Photodiagnosis Photodyn Ther; 2020 Mar; 29():101588. PubMed ID: 31704507
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting ABCG2 could potentially enhance the efficacy of hypericin-mediated photodynamic therapy in spheroidal cell models of colorectal cancer.
Khot MI; Perry SL; Maisey T; Armstrong G; Andrew H; Hughes TA; Kapur N; Jayne DG
Photodiagnosis Photodyn Ther; 2018 Sep; 23():221-229. PubMed ID: 29969677
[TBL] [Abstract][Full Text] [Related]
4. Hypericin-mediated photodynamic therapy inhibits growth of colorectal cancer cells via inducing S phase cell cycle arrest and apoptosis.
Hu J; Song J; Tang Z; Wei S; Chen L; Zhou R
Eur J Pharmacol; 2021 Jun; 900():174071. PubMed ID: 33811836
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy of transitional cell carcinoma multicellular tumor spheroids with hypericin.
Kamuhabwa AA; Huygens A; De Witte PA
Int J Oncol; 2003 Nov; 23(5):1445-50. PubMed ID: 14532989
[TBL] [Abstract][Full Text] [Related]
6. Hypericin-P123-photodynamic therapy in an ex vivo model as an alternative treatment approach for onychomycosis caused by Fusarium spp.
Conrado PCV; Sakita KM; Arita GS; Gonçalves RS; Cesar GB; Caetano W; Hioka N; Voidaleski MF; Vicente VA; Svidzinski TIE; Bonfim-Mendonça PS; Kioshima ES
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102414. PubMed ID: 34186264
[TBL] [Abstract][Full Text] [Related]
7. Accumulation and penetration behavior of hypericin in glioma tumor spheroids studied by fluorescence microscopy and confocal fluorescence lifetime imaging microscopy.
Bassler MC; Rammler T; Wackenhut F; Zur Oven-Krockhaus S; Secic I; Ritz R; Meixner AJ; Brecht M
Anal Bioanal Chem; 2022 Jul; 414(17):4849-4860. PubMed ID: 35538227
[TBL] [Abstract][Full Text] [Related]
8. Hypericin-assisted photodynamic therapy against anaplastic thyroid cancer.
Kim H; Kim SW; Seok KH; Hwang CW; Ahn JC; Jin JO; Kang HW
Photodiagnosis Photodyn Ther; 2018 Dec; 24():15-21. PubMed ID: 30118906
[TBL] [Abstract][Full Text] [Related]
9. Differential susceptibility of primary cultured human skin cells to hypericin PDT in an in vitro model.
Popovic A; Wiggins T; Davids LM
J Photochem Photobiol B; 2015 Aug; 149():249-56. PubMed ID: 26114219
[TBL] [Abstract][Full Text] [Related]
10. Review of three-dimensional spheroid culture models of gynecological cancers for photodynamic therapy research.
Wu R; Yuen J; Cheung E; Huang Z; Chu E
Photodiagnosis Photodyn Ther; 2024 Feb; 45():103975. PubMed ID: 38237651
[TBL] [Abstract][Full Text] [Related]
11. In vitro photodynamic therapy of childhood rhabdomyosarcoma.
Seitz G; Warmann SW; Armeanu S; Heitmann H; Ruck P; Hoffman RM; Fuchs J; Wessels JT
Int J Oncol; 2007 Mar; 30(3):615-20. PubMed ID: 17273762
[TBL] [Abstract][Full Text] [Related]
12. Hypericin-photodynamic therapy inhibits the growth of adult T-cell leukemia cells through induction of apoptosis and suppression of viral transcription.
Xu L; Zhang X; Cheng W; Wang Y; Yi K; Wang Z; Zhang Y; Shao L; Zhao T
Retrovirology; 2019 Feb; 16(1):5. PubMed ID: 30782173
[TBL] [Abstract][Full Text] [Related]
13. In vitro photodynamic therapy in pediatric epithelial liver tumors promoted by hypericin.
Seitz G; Krause R; Fuchs J; Heitmann H; Armeanu S; Ruck P; Warmann SW
Oncol Rep; 2008 Nov; 20(5):1277-82. PubMed ID: 18949433
[TBL] [Abstract][Full Text] [Related]
14. Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery.
Damke GMZF; Souza RP; Montanha MC; Damke E; Gonçalves RS; César GB; Kimura E; Caetano W; Hioka N; Consolaro MEL
Anticancer Agents Med Chem; 2020; 20(11):1352-1367. PubMed ID: 30387402
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared Transillumination and Photodynamic Therapy Using Hypericin in Animal Laryngeal Tumors.
Lee H; Kim SW; Kwon DY; Kang HW; Jung MJ; Kim JH; Ahn YC; Oak C
Tissue Eng Regen Med; 2021 Dec; 18(6):941-951. PubMed ID: 34495501
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of FosPeg® photodynamic effect on nasopharyngeal carcinoma cells in 2D and 3D models.
Wu RWK; Chu ESM; Yuen JWM; Huang Z
J Photochem Photobiol B; 2020 Sep; 210():111987. PubMed ID: 32801063
[TBL] [Abstract][Full Text] [Related]
17. Response surface method optimization of a novel Hypericin formulation in P123 micelles for colorectal cancer and antimicrobial photodynamic therapy.
Montanha MC; Silva LL; Pangoni FBB; Cesar GB; Gonçalves RS; Caetano W; Hioka N; Tominaga TT; Consolaro MEL; Diniz A; Kimura E
J Photochem Photobiol B; 2017 May; 170():247-255. PubMed ID: 28454049
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic Efficacy of Cercosporin in 3D Tumor Cell Cultures.
Grigalavicius M; Mastrangelopoulou M; Arous D; Juzeniene A; Ménard M; Skarpen E; Berg K; Theodossiou TA
Photochem Photobiol; 2020 May; 96(3):699-707. PubMed ID: 32125700
[TBL] [Abstract][Full Text] [Related]
19. The diverse roles of glutathione-associated cell resistance against hypericin photodynamic therapy.
Theodossiou TA; Olsen CE; Jonsson M; Kubin A; Hothersall JS; Berg K
Redox Biol; 2017 Aug; 12():191-197. PubMed ID: 28254657
[TBL] [Abstract][Full Text] [Related]
20. Hypericin in photobiological assays: An overview.
de Andrade GP; de Souza TFM; Cerchiaro G; Pinhal MADS; Ribeiro AO; Girão MJBC
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102343. PubMed ID: 34038765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]